Covista Inc. (CVSA) · Oct 29, 2026 · Earnings

Covista earnings beat; FY27 guidance rises as CFO retires

Beat — Adj. EPS $2.19 vs ~$1.86 consensus; revenue $511.5M vs ~$498M

Covista earnings beat published Q1 estimates, with enrollment-led growth lifting FY27 revenue and adjusted EPS guidance despite a planned CFO retirement.

Covista is in the middle of a healthcare-education expansion strategy, using Chamberlain, Walden, and its medical schools to grow enrollment and address the U.S. healthcare workforce shortage; Walden is currently the main growth engine, while Chamberlain is expanding campuses and employer partnerships.

The quarter cleared the published bar, not just the company’s own narrative. Revenue reached $511.5 million versus a published consensus near $498 million, while adjusted EPS was $2.19 versus roughly $1.86 expected. That makes this a genuine earnings beat, with the upside broad enough to support the guidance increase rather than relying on a one-off accounting item. (Financial Highlights)

MetricQ1 FY27Q1 FY26Consensus
Revenue (Financial Highlights)$511.5M (+10.7%)$462.3M~$498M
Adjusted EPS (Financial Highlights)$2.19 (+25.1%)$1.75~$1.86
Adjusted EBITDA (Financial Highlights)$131.2M (+17.1%)$112.0M
Total enrollment (First quarter highlights)104,713 (+7.6%)97,338

Growth is increasingly concentrated in Walden, but the portfolio is still moving forward. Walden enrollment rose 12.8% and revenue rose 14.1%, while Medical and Veterinary produced 10.0% revenue growth and 33.0% operating-income growth. Chamberlain remains the weaker spot: enrollment grew only 1.3% and operating income 4.4%, with its margin slipping to 13.9% from 14.3%. 〔0〕

Management raised the full-year framework, making the beat more consequential. FY27 revenue guidance moved to $2.060 billion-$2.095 billion from $2.050 billion-$2.090 billion, and adjusted EPS guidance moved to $9.00-$9.20 from $8.90-$9.15. The increases are modest, but they confirm that the enrollment momentum is translating into a higher earnings base rather than merely pulling results forward. (Fiscal Year 2027 Outlook)

Capital allocation and financing reinforce the operating result. Covista repurchased $84 million of shares, reduced its Term Loan B pricing by 25 basis points, and ended the quarter at 0.5x net leverage. Those actions improve financial flexibility, although cash fell to $222.2 million after buybacks and $163 million of debt repayment. (Capital allocation; Balance Sheets; Cash Flow statement)

The CFO retirement is a manageable but real execution variable. Robert Phelan will remain until a successor is named, and the filing describes the move as planned with no immediate change in responsibilities; the risk is therefore succession continuity, not an abrupt financial-control disruption. (Management Update) 〔1〕

Bottom line: This is a real beat with a modest but credible guidance lift, led by Walden and improving margins. The CFO transition adds a watch item, but it does not outweigh the stronger operating trajectory shown in this filing.

What to watch next

CFO successor announcement

Original filing on SEC EDGAR

More Covista Inc. news

Covista earnings beat; FY27 guidance rises as CFO retires | CVSA Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.